Nikko Asset Management Americas’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
Other funds holding BNR
KCM
CL
HH
AIP
Nikko Asset Management Americas's BNR Position: Q2 2026 in Review
Nikko Asset Management Americas reduced its Burning Rock Biotech (BNR) stake by 1.4% in Q2 2026, selling an estimated $5.85K and leaving 29,724 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #188.
Nikko Asset Management Americas first reported a position in BNR in Q4 2020 and has held it in 23 quarters since. The position peaked at $23.2M in Q1 2021. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.
- Nikko Asset Management Americas held 29,724 shares of Burning Rock Biotech worth $258K as of Q2 2026.
- Nikko Asset Management Americas sold 413 Burning Rock Biotech shares in Q2 2026, an estimated $5.85K.
- Burning Rock Biotech made up ﹤0.01% of Nikko Asset Management Americas's portfolio in Q2 2026, its #188 holding.
- Nikko Asset Management Americas first reported a position in Burning Rock Biotech in Q4 2020 and has held it in 23 quarters since.
- Nikko Asset Management Americas's Burning Rock Biotech position peaked at $23.2M in Q1 2021.
- 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.
Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.